Search Results 1781-1790 of 39016 for Two-phase

  1. Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma - Mayo Clinic

    This is 2-part, randomized, open label, multi-center, parallel group, phase III study comparing the efficacy and safety of LGX818 plus MEK162 to vemurafenib and ...

  2. Mayo Clinic Q and A: Melanoma stage determines treatment plan

    The treatment for thinner melanomas generally removes the melanoma with a margin of tissue, typically 1 to 2 centimeters of normal tissue. If the sentinel lymph ...

  3. HPV Infection Clinical Trials - Mayo Clinic Research

    The purpose of Phase II part 2 is to compare the Progression-Free Survival (PFS) of TG4001 in combination with avelumab vs avelumab alone in patients with ...

  4. A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma - Mayo Clinic

    Overview. Tab Title Description. Study typeInterventional Study phase2/3. Study ... * Two scans to confirm progression are required: at least 1 scan at ...

  5. Heart Disease Clinical Trials - Mayo Clinic Research

    The investigators will do the study in two phases. The first phase will be a pilot study on up to 18 participants [patients 60 years or older with coronary ...

  6. Olaparib Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy. - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  7. RECOVER-SLEEP: Platform Protocol - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  8. Mayo Clinic Q and A: Diagnosing ovarian cancer

    Women have two ovaries — one on each side of the uterus. They produce ... In stage 2, the cancer has moved beyond the ovaries but is still within the ...

  9. Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164) - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  10. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3) - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...